Longevity Gene Project (LGP)
Lead to new drug therapies that might help people live longer, healthier lives and avoid or significantly delay age-related diseases such as Alzheimer's disease, type 2 diabetes and cardiovascular disease.
- National Institute of Aging and the Glenn Foundation
- Study design
- Population cohort
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Elderly people between the ages of 95 and 112 and on their children.
Availability of data and biosamples
No coverage data about the variables classifications are available.